Global Nitric Oxide Therapy System Market Size, Competition Landscape and Supply Chain Research Report 2025

Research Summary

A nitric oxide therapy system is a medical device used to deliver controlled amounts of nitric oxide (NO) gas to patients in a clinical setting. Nitric oxide therapy is commonly used in the treatment of respiratory conditions, particularly in neonates with persistent pulmonary hypertension (PPHN) or acute respiratory distress syndrome (ARDS). The therapy system typically consists of a delivery device or ventilator integrated with a nitric oxide generator that produces the gas on-site. Nitric oxide is delivered to the patient via inhalation, where it acts as a potent vasodilator, relaxing the smooth muscle in the pulmonary vasculature and improving oxygenation of the blood. This helps to reduce pulmonary hypertension and enhance oxygen exchange in the lungs. The nitric oxide therapy system allows for precise control of the concentration of nitric oxide delivered and can be adjusted based on the patient’s specific needs. Proper monitoring and titration of nitric oxide gas levels are crucial to ensure safe and effective treatment. Nitric oxide therapy has demonstrated clinical benefits in improving oxygenation, reducing the need for extracorporeal membrane oxygenation (ECMO), and enhancing outcomes in patients with respiratory conditions.

According to WENKH research statistics, the global Nitric Oxide Therapy System market sales revenue reached  Million USD in 2024 and is expected to reach  Million USD by 2032, with a compound annual growth rate (CAGR) of  % from 2025 to 2032. Among them, the Asia-Pacific Nitric Oxide Therapy System market has experienced rapid changes in recent years, reaching  Million USD in 2024, accounting for approximately  % of the global market share. It is projected to reach  Million USD by 2032.

The global Nitric Oxide Therapy System market is highly competitive, with key market players including Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, EKU Elektronik, GeNO, SLE, International Biomedical, Praxair, Mallinckrodt Pharmaceuticals, Vapotherm, Linde Group, etc. This report categorizes the competitive landscape of the global Nitric Oxide Therapy System market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Nitric Oxide Therapy System market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Nitric Oxide Therapy System industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Nitric Oxide Therapy System and their downstream application fields.

In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Nitric Oxide Therapy System in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Nitric Oxide Therapy System market. By considering local policies, this report evaluates the market prospects of Nitric Oxide Therapy System in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

Bellerophon Therapeutics

BOC Healthcare

Dan Hammer Health

EKU Elektronik

GeNO

SLE

International Biomedical

Praxair

Mallinckrodt Pharmaceuticals

Vapotherm

Linde Group

Product Segment

Protable System

Fixed System

Product Application

Hospitals

Homecare Settings

Others

Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Nitric Oxide Therapy System Industry Chain Analysis

Chapter 3: Global Nitric Oxide Therapy System Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Nitric Oxide Therapy System Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Nitric Oxide Therapy System Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Nitric Oxide Therapy System Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Nitric Oxide Therapy System Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Nitric Oxide Therapy System Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Nitric Oxide Therapy System Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Nitric Oxide Therapy System Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Nitric Oxide Therapy System Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source

Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.